WT1 gene expression: Useful marker for minimal residual disease in childhood myelodysplastic syndromes and juvenile myelo-monocytic leukemia?

European Journal of Haematology

Volumn 73, Issue 1, 2004, Pages 25-28

  Bader, Peter ^a   Niemeyer, Charlotte ^b   Weber, Gerrit ^a   Coliva, Tiziana ^c   Rossi, Vincenzo ^c   Kreyenberg, Hermann ^a   Gerecke, Anja ^b   Biondi, Andrea ^c  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c SAN GERARDO HOSPITAL   (Italy)

Author keywords

Childhood; Juvenile myelo monocytic leukemia; Minimal residual disease; Myelodysplastic syndromes; WT1 gene expression

Indexed keywords

WT1 PROTEIN;

ADVANCED CANCER; ARTICLE; BLOOD SAMPLING; BONE MARROW BIOPSY; CANCER GRADING; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE MARKER; GENE EXPRESSION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MINIMAL RESIDUAL DISEASE; MYELODYSPLASTIC SYNDROME; MYELOMONOCYTIC LEUKEMIA; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL;

ANEMIA, REFRACTORY, WITH EXCESS OF BLASTS; BONE MARROW; CHILD; GENE EXPRESSION; HUMANS; LEUKEMIA, MYELOCYTIC, ACUTE; LEUKEMIA, MYELOMONOCYTIC, ACUTE; MYELODYSPLASTIC SYNDROMES; NEOPLASM, RESIDUAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL; WT1 PROTEINS;

EID: 3042663013     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2004.00260.x     Document Type: Article

References (15)

1. ROGGE T, NIEMEYER CM. Myelodysplastic syndromes in childhood. Onkologie 2000;23:18-24.
2. NIEMEYER CM, ARICO M, BASSO G et al. Chronic myelomonocytic leukemia in childhood: a retrospective analysis of 110 cases. European Working Group on Myelodysplastic Syndromes in Childhood (EWOG-MDS). Blood 1997;89:3534-3543.
3. HASLE H, NIEMEYER CM, CHESSELLS JM, BAUMANN I, BENNETT JM, KERNDRUP G, HEAD DR. A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases. Leukemia 2003;17:277-282.
4. ARICO M, BIONDI A, PUI CH. Juvenile myelomonocytic leukemia. Blood 1997;90:479-488.
5. BADER P, STOLL K, HUBER S et al. Characterization of lineage-specific chimaerism in patients with acute leukaemia and myelodysplastic syndrome after allogeneic stem cell transplantation before and after relapse. Br J Haematol 2000;108:761-768.
6. MENSSEN HD, RENKL HJ, RODECK U, MAURER J, NOTTER M, SCHWARTZ S, REINHARDT R, THIEL E. Presence of Wilms' tumor gene (WT1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias. Leukemia 1995;9:1060-1067.
7. BRIEGER J, WEIDMANN E, MAURER U, HOELZER D, MITROU PS, BERGMANN L. The Wilms' tumor gene is frequently expressed in acute myeloblastic leukemias and may provide a marker for residual blast cells detectable by PCR. Ann Oncol 1995;6:811-816.
8. TRKA J, KALINOVA M, HRUSAK O et al. Real-time quantitative PCR detection of WT1 gene expression in children with AML: prognostic significance, correlation with disease status and residual disease detection by flow cytometry. Leukemia 2002;16:1381-1389.
9. TAMAKI H, OGAWA H, INOUE K et al. Increased expression of the Wilms tumor gene (WT1) at relapse in acute leukemia (letter). Blood 1996;88:4396-4398.
10. INOUE K, OGAWA H, SONODA Y et al. Aberrant overexpression of the Wilms tumor gene (WT1) in human leukemia. Blood 1997;89:1405-1412.
11. INOUE K, OGAWA H, YAMAGAMI T et al. Long-term followup of minimal residual disease in leukemia patients by monitoring WT1 (Wilms tumor gene) expression levels. Blood 1996;88:2267-2278.
12. BERGMANN L, MIETHING C, MAURER U, BRIEGER J, KARAKAS T, WEIDMANN E, HOELZER D. High levels of Wilms' tumor gene (wt1) mRNA in acute myeloid leukemias are associated with a worse long-term outcome. Blood 1997;90:1217-1225.
13. TAMAKI H, OGAWA H, OHYASHIKI K et al. The Wilms' tumor gene WT1 is a good marker for diagnosis of disease progression of myelodysplastic syndromes. Leukemia 1999;13:393-399.
14. CILLONI D, GOTTARDI E, MESSA F et al. Significant correlation between the degree of WT1 expression and the International Prognostic Scoring System Score in patients with myelodysplastic syndromes. J Clin Oncol 2003; 21:1988-1995.
15. SAKO M, OGAWA H, OKAMURA J, TAMAKI H, NAKAHATA T, KISHIMOTO SUGIYAMA. Abnormal expression of the Wilms'tumor gene WT1 in juvenile chronic myeloid leukemia and infantile monosomy 7 syndrome. Leukemia Res 1998;22:965-967.